Article Sidebar

PDF
Date Published: 11/07/2022
Online Published: 11/07/2022
Abstract Views: 263
Views PDF: 119
DOI: https://doi.org/10.55046/vjrnm.28.485.2017
Issue
No. 28 (2017)
Section
Scientific research
How to Cite
Vu, L. M., Vu, H. L., Nguyen, M. D., Phan, N. A., & Le, T. D. (2022). Role of partial splenic embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia. Vietnamese Journal of Radiology and Nuclear Medicine, 28, 52-57. https://doi.org/10.55046/vjrnm.28.485.2017

Role of partial splenic embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia

Vu Le Minh1, Vu Hoai Linh1, Nguyen Mau Dinh1, Phan Nhat Anh1, Le Thanh Dung1,
1 Viet Duc Friendship Hospital

Main Article Content

Abstract

SUMMARY


Objective: To evaluate the safety and efficacy of partial splenic embolization (PSE) in treatment of hypersplenism due to cirrhosis.
Patients and Methods: From December 2014 to February 2017, 17 cirrhotic patients with splenomegaly who have thrombocytopenia were treated with PSE in Viet Duc Hospital.
Results: PSE was successfully performed in 17/17 patients with increased thrombocytes counts in the number post - PSE.
The splenic infarction volume < 50%, 50-70% and > 70% are achieved in 5/17 patients, 10/17 patients and 2/17 patients respectively. 17/17 patients experienced post-embolization
syndrome, 4/17 patients developed pleural effusion, 5/17 patients developed ascites, portal vein thrombosis was found in 1/17
patients.
Conclusion: PSE is a safe and efficient treatment of hypersplenism in patients with cirrhosis and thrombocytopenia.

Article Details

Keywords

hypersplenism, thrombocytopenia, partial splenic embolization

References

TÀI LIỆU THAM KHẢO
1. Noguchi, H., et al., Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients
with hypersplenism. Hepatology, 1995. 22(6): p. 1682-1688.
2. Schuppan, D. and N.H. Afdhal, Liver cirrhosis. The Lancet, 2008. 371(9615): p. 838-851.
3. Poulin, E., J. Mamazza, and C. Schlachta, Splenic artery embolization before laparoscopic splenectomy. Surgical endoscopy, 1998. 12(6): p. 870-875.
4. Gangireddy, V., et al., Management of thrombocytopenia in advanced liver disease. Canadian Journal of Gastroenterology and Hepatology, 2014. 28(10): p. 558-564.
5. Miyake, Y., et al., Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic
hepatitis C patients with thrombocytopenia. Hepatology Research, 2008. 38(10): p. 980-986.
6. Kauffman, C.R., et al., Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic
chemotherapy. Cancer, 2008. 112(10): p. 2283-2288.
7. Ooka, Y., et al., Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia. BioMed research international, 2014. 2014.
8. Elmonem, S.A., et al., The outcome of partial splenic embolization for hypersplenism in the cirrhotic patients.
The Egyptian Journal of Radiology and Nuclear Medicine, 2011. 42(1): p. 35-42.
9. Zhu, K., et al., Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Digestive and Liver Disease, 2009. 41(6): p. 411-416.
10. Sangro, B., et al., Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology, 1993.
18(2): p. 309-314.
11. Oriuchi, N., et al., A new, accurate and conventional five-point method for quantitative evaluation of ascites using plain computed tomography in cancer patients. Japanese journal of clinical oncology, 2005. 35(7): p. 386- 390.